Free Trial

Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

Silicon Laboratories logo with Computer and Technology background

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Silicon Laboratories Inc. (NASDAQ:SLAB). In a filing disclosed on May 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Silicon Laboratories stock on April 14th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Beiersdorf Aktiengesellschaft OTCMKTS: BDRFF on 5/2/2025.
  • Purchased $1,001 - $15,000 in shares of Alkami Technology NASDAQ: ALKT on 4/30/2025.
  • Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of DXC Technology NYSE: DXC on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of DOW NYSE: DOW on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of Zions Bancorporation, National Association NASDAQ: ZION on 4/29/2025.
  • Purchased $1,001 - $15,000 in shares of O'Reilly Automotive NASDAQ: ORLY on 4/29/2025.
  • Purchased $1,001 - $15,000 in shares of McKesson NYSE: MCK on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of Humana NYSE: HUM on 4/29/2025.

Silicon Laboratories Stock Up 5.4 %

Shares of NASDAQ SLAB traded up $5.97 during trading on Friday, reaching $117.04. 306,143 shares of the stock were exchanged, compared to its average volume of 328,327. The company has a market capitalization of $3.80 billion, a price-to-earnings ratio of -19.70 and a beta of 1.36. The business's 50-day moving average price is $108.95 and its 200 day moving average price is $120.50. Silicon Laboratories Inc. has a twelve month low of $82.82 and a twelve month high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). The firm had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The firm's revenue was up 91.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($1.19) EPS. As a group, sell-side analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Institutional Trading of Silicon Laboratories

Several institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new stake in shares of Silicon Laboratories during the 4th quarter valued at about $14,252,000. Arizona State Retirement System boosted its stake in Silicon Laboratories by 1.8% in the fourth quarter. Arizona State Retirement System now owns 9,360 shares of the semiconductor company's stock valued at $1,163,000 after acquiring an additional 167 shares during the period. Franklin Resources Inc. grew its holdings in shares of Silicon Laboratories by 1.9% during the third quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company's stock valued at $27,001,000 after purchasing an additional 4,278 shares during the last quarter. Barclays PLC raised its position in shares of Silicon Laboratories by 23.4% during the 3rd quarter. Barclays PLC now owns 70,568 shares of the semiconductor company's stock worth $8,157,000 after purchasing an additional 13,363 shares during the period. Finally, Arkadios Wealth Advisors acquired a new stake in shares of Silicon Laboratories during the 4th quarter worth approximately $237,000.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Stifel Nicolaus reduced their price target on Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a report on Thursday, April 17th. Barclays reduced their target price on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 22nd. KeyCorp lifted their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 22nd. StockNews.com cut shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a report on Thursday, March 27th. Finally, Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Silicon Laboratories has an average rating of "Hold" and a consensus price target of $129.00.

Read Our Latest Stock Report on Silicon Laboratories

Insider Buying and Selling

In other Silicon Laboratories news, Director William G. Bock sold 1,000 shares of the business's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now directly owns 31,115 shares of the company's stock, valued at $4,649,514.45. The trade was a 3.11 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Christy Wyatt sold 546 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total transaction of $57,029.70. Following the completion of the sale, the director now owns 8,492 shares in the company, valued at $886,989.40. The trade was a 6.04 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Silicon Laboratories

(Get Free Report)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

Featured Stories

Should You Invest $1,000 in Silicon Laboratories Right Now?

Before you consider Silicon Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.

While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines